McLeod, D C <br/><br/>
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.  [electronic resource] 

 -  The Annals of pharmacotherapy   
 - 956-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1060-0280 
<br/><br/><label>Standard No.: </label>10.1177/106002809302700725  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Hemorrhage--chemically induced<br/>Humans<br/>Myocardial Infarction--drug therapy<br/>North Carolina--epidemiology<br/>Retrospective Studies<br/>Streptokinase--adverse effects<br/>Thrombolytic Therapy--adverse effects<br/>Tissue Plasminogen Activator--adverse effects